HomeGreen ColumnUnderstanding the environmental impact of hospital pharmacy supply chains

Understanding the environmental impact of hospital pharmacy supply chains

Published on

The pharmacy sector produces a range of environmental effects, encompassing greenhouse gas emissions, ecological ramifications of pharmaceuticals in the environment, and plastic waste from pharmaceutical packaging. Let’s delve into their impact on our climate, our health, and discuss actions we can take to mitigate the harm.

Greenhouse gas emissions. Healthcare contributes just under five per cent of Canada’s total greenhouse gas emissions. A quarter of these emissions stem from the production of pharmaceuticals with 90 per cent of those emissions originating from supply chains and the remaining ten per cent from healthcare facilities. This major contributor to climate change and its adverse impacts on health include an increased frequency of heat-related illness, exacerbations of asthma and chronic obstructive pulmonary disease due to exposure of wildfire smoke made more due to climate change and worsening of mental disorders. 

Ecological effects of pharmaceuticals on the environment. Pharmaceuticals enter the environment through various pathways, including human excretion and improper disposal, leading to contamination of waterways and landfills. This contamination poses ecological risks as pharmaceuticals bioaccumulate in the food chain, potentially affecting humans who consume these organisms. Research has identified pharmaceutical levels in the environment that induce toxicity and provoke worries regarding antimicrobial resistance. This renders infections more challenging to manage and heightens the likelihood of disease spread, severe illness and death.

Plastic waste from pharmaceutical packaging. Plastic waste poses a major concern, constituting 30 per cent of hospital waste. In Canada, 87 per cent of plastics, including healthcare-related ones, find their way into landfills or the environment. Packaging makes up almost half of this waste. Exposure to plastic harms wildlife and releases harmful chemicals such as phthalates and bisphenol A, disrupting hormone levels and reproduction. These chemicals are linked to health issues like metabolic abnormalities, reproductive dysfunction, and cancer in humans.

Despite these issues, however, there is still plenty of ways that healthcare professionals can help to make Canada’s drug supply more sustainable.

There are many things individual pharmacy professionals, for instance, could be doing to help. One such way could be adding environmental impact to the list of considerations one must make when choosing a medication for a patient, alongside efficacy and cost-effectiveness. By considering environmental impact in clinical decision-making, such as promoting eco-friendly inhalers and identifying unnecessary medications to deprescribe, pharmacy professionals can reduce environmental harm while bettering care.

Beyond individual efforts, hospitals can make the active choice to work with suppliers who are committed to green practices and can establish their own sustainability committees to advocate for more eco-friendly procurement. By implementing green inventory procurement and management practices, hospital pharmacies can further reduce waste and emissions. Collaboration can also extend further with drug manufacturers and Health Canada to integrate these considerations in their drug approval processes. 

The environmental footprint of healthcare is undeniably significant, yet it holds the potential for change. Through a green-minded approach across the entire supply chain, we can diminish its adverse effects on both the planet’s health and the well-being of our patients

For a more in-depth clinical perspective on this topic, I encourage readers to explore my Clinical Pearl and Resource Spotlight on CSHP.ca.

By Huy Pham

Huy Pham is a former CSHP student and Doctor of Pharmacy candidate at the Leslie Dan Faculty of Pharmacy at the University of Toronto.

Latest articles

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill researchers have developed an AI tool called SIDISH that identifies high-risk cancer cells driving aggressive disease, enabling more precise and targeted treatment strategies. By linking single-cell data with patient outcomes, the tool can predict disease progression and simulate responses to potential drug targets, helping accelerate drug discovery and repurposing. While still in development, SIDISH shows promise for advancing personalized cancer care and improving outcomes across multiple tumour types.

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society is urging provinces to lower the colorectal cancer screening age from 50 to 45, citing rising rates among younger adults and evidence that earlier screening could prevent over 15,000 cases and 6,100 deaths. Younger patients are more often diagnosed at advanced stages, making early detection critical. Expanding access to simple screening tools like FIT tests could significantly improve outcomes and save lives.

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.

Doctors report false health information, lack of health data sharing put patient care at risk

A new CMA survey reveals major risks to patient care in Canada, with 99% of physicians reporting that disconnected health systems limit access to critical patient information and nearly half witnessing serious adverse outcomes as a result. At the same time, 97% of doctors say they have intervened to address harm caused by false or misleading online health information, including AI-generated advice. The findings highlight the urgent need for integrated digital health systems and stronger efforts to promote reliable health information.

More like this

Helping the planet, one inhaler at a time

HN Summary • Environmental impact: At St. Joseph’s Health Care London and London Health Sciences...

How to “green” operating rooms: new guideline advises reduce, reuse, recycle, and rethink

Reduce, reuse, recycle, and rethink can be applied in Canadian operating rooms (ORs) to...

Building a greener, safer hospital

HN Summary • Sustainable, Low-Impact Design: The new West Lincoln Memorial Hospital (WLMH) in Grimsby,...

From hidden emissions to climate leadership: Tackling nitrous oxide in health care

HN Summary • Nitrous oxide (N2O), a greenhouse gas nearly 300 times more potent than...

How Health Care Leaders Can Build a Robust AI Risk Management Framework

Artificial intelligence is rapidly moving from pilot projects to enterprise-wide deployment in health care....

Growing pressures facing hospital sector

At recent  2026/27 Pre-Budget Consultations, held by the Ministry of Finance in North York,...